Gerges, A., & Canning, U. (2025). High-Risk Neuroblastoma Stage 4 (NBS4): Developing a Medicinal Chemistry Multi-Target Drug Approach. Molecules (Basel, Switzerland), 30(10), 2211. https://doi.org/10.3390/molecules30102211
Chicago Style (17th ed.) CitationGerges, Amgad, and Una Canning. "High-Risk Neuroblastoma Stage 4 (NBS4): Developing a Medicinal Chemistry Multi-Target Drug Approach." Molecules (Basel, Switzerland) 30, no. 10 (2025): 2211. https://doi.org/10.3390/molecules30102211.
MLA (9th ed.) CitationGerges, Amgad, and Una Canning. "High-Risk Neuroblastoma Stage 4 (NBS4): Developing a Medicinal Chemistry Multi-Target Drug Approach." Molecules (Basel, Switzerland), vol. 30, no. 10, 2025, p. 2211, https://doi.org/10.3390/molecules30102211.
Warning: These citations may not always be 100% accurate.